Significant survival benefit of adjuvant chemotherapy after concurrent chemoradiotherapy in locally advanced high-risk nasopharyngeal carcinoma. - Wikidata - awgldk - TriplyDB

Significant survival benefit of adjuvant chemotherapy after concurrent chemoradiotherapy in locally advanced high-risk nasopharyngeal carcinoma.

Significant survival benefit of adjuvant chemotherapy after concurrent chemoradiotherapy in locally advanced high-risk nasopharyngeal carcinoma.

http://www.wikidata.org/entity/Q37620559

about

Significant survival benefit of adjuvant chemotherapy after concurrent chemoradiotherapy in locally advanced high-risk nasopharyngeal carcinoma.

http://www.wikidata.org/entity/Q37620559

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 02 February 2017

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Significant survival benefit o ...... risk nasopharyngeal carcinoma.

@en

Significant survival benefit o ...... risk nasopharyngeal carcinoma.

@nl

type

label

Significant survival benefit o ...... risk nasopharyngeal carcinoma.

@en

Significant survival benefit o ...... risk nasopharyngeal carcinoma.

@nl

prefLabel

Significant survival benefit o ...... risk nasopharyngeal carcinoma.

@en

Significant survival benefit o ...... risk nasopharyngeal carcinoma.

@nl

P1433

Q37620559-929ADB8D-B736-43AA-ABE9-0CE325930911

P1476

Q37620559-A3747D83-0867-416E-99CC-DB9B9D749070

P2093

Q37620559-06909B28-B5C2-41E7-BD80-C4633C44772A

Q37620559-160C830B-A8AF-4BEC-9B5C-E0446BC598A6

Q37620559-177C2C0E-6287-41C6-BA2F-AB36FD61DA0B

Q37620559-2E3B913E-4C05-4F45-B232-96F4BB284E76

Q37620559-6B75C27D-319A-4EA0-A372-82334CDEA95D

Q37620559-827C8F44-89CB-4C9E-AC7C-71EE075AD000

Q37620559-8851A2AA-7C5D-45E6-8EDD-714AF92B8206

Q37620559-A2DFF740-D3D7-4B59-8D13-82758C84404F

Q37620559-A8A6C728-133F-42FD-8EAA-1DDA2860CB30

Q37620559-B765AB6C-3E2F-4F62-848E-771D2BB19E3A

P2860

Q37620559-1D899933-C1EF-4FEC-BA0E-927464AD5141

Q37620559-2D69666D-9BCB-4D18-901A-E12450F44590

Q37620559-334F09A6-0C71-4F73-A1A6-DC4A4BF5F670

Q37620559-652F8DE4-614B-4FCD-9309-BC548F919CDE

Q37620559-6F41AA3B-8BF6-46D8-8BA2-F66C5B4FE708

Q37620559-729814BD-4E1A-4AB5-AAA6-1A6F5DFBA943

Q37620559-73B82A0D-DFEC-48E2-BE84-7C0736C5ED6D

Q37620559-78538ACC-7503-48CA-A4EE-BB7F9426455A

Q37620559-7AF304DA-993E-4940-89A5-9F0A75A06D6F

Q37620559-8B481CC3-A13E-4EA3-92A7-8EACD7186F62

P2888

Q37620559-99AF2142-04CC-4D01-8E70-60D81E639D07

P304

Q37620559-D96A433E-FFB4-4520-AB33-9917633B05A7

P31

Q37620559-5E7EAED9-2EB4-4002-96CB-8C9186F9010A

P356

Q37620559-EE917CAA-6472-436B-8A1E-97D7F1AADA26

P407

Q37620559-C152C0D4-9873-4CA2-B3C5-8EEBD40C8C0A

P478

Q37620559-7498C200-7EB5-452A-8ED9-DFAB596C33D7

P577

Q37620559-AF447F25-E450-4D2B-89E7-E6164530632C

P698

Q37620559-B324B1BD-660D-4C90-86E1-1ADEE9A2B627

P921

Q37620559-FB126BC0-F829-418C-AEBE-8544BF47C537

P932

Q37620559-D7E8FF4C-8371-4765-BF0B-68600F03EF8F

P356

P1433

Scientific Reports

P1476

Significant survival benefit o ...... risk nasopharyngeal carcinoma.

@en

P2093

Bin-Bin Yu

http://www.w3.org/2001/XMLSchema#string

Fang Su

http://www.w3.org/2001/XMLSchema#string

Guo-Xiang Lin

http://www.w3.org/2001/XMLSchema#string

Kai-Hua Chen

http://www.w3.org/2001/XMLSchema#string

Ling Li

http://www.w3.org/2001/XMLSchema#string

Qiu-Lu Zhong

http://www.w3.org/2001/XMLSchema#string

Si-Kai Nong

http://www.w3.org/2001/XMLSchema#string

Song Qu

http://www.w3.org/2001/XMLSchema#string

Wei Zhao

http://www.w3.org/2001/XMLSchema#string

Xiao-Dong Zhu

http://www.w3.org/2001/XMLSchema#string

P2860

Global cancer statistics, 2012

Concurrent chemoradiotherapy followed by adjuvant chemotherapy compared with concurrent chemoradiotherapy alone for the treatment of locally advanced nasopharyngeal carcinoma: a retrospective controlled study.

Influence of gender and age on the survival of patients with nasopharyngeal carcinoma

Establishment of an integrated model incorporating standardised uptake value and N-classification for predicting metastasis in nasopharyngeal carcinoma

Tumor Regression and Patterns of Distant Metastasis of T1-T2 Nasopharyngeal Carcinoma with Intensity-Modulated Radiotherapy.

Low Prognostic Nutritional Index (PNI) Predicts Unfavorable Distant Metastasis-Free Survival in Nasopharyngeal Carcinoma: A Propensity Score-Matched Analysis.

Neoadjuvant chemotherapy in locally advanced nasopharyngeal carcinoma: Defining high-risk patients who may benefit before concurrent chemotherapy combined with intensity-modulated radiotherapy.

Prognostic Impact of Plasma Epstein-Barr Virus DNA in Patients with Nasopharyngeal Carcinoma Treated using Intensity-Modulated Radiation Therapy

Plasma Epstein-Barr viral DNA complements TNM classification of nasopharyngeal carcinoma in the era of intensity-modulated radiotherapy.

Chemoradiotherapy regimens for locoregionally advanced nasopharyngeal carcinoma: A Bayesian network meta-analysis.

P2888

P304

41449

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SREP41449

http://www.w3.org/2001/XMLSchema#string

P407

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2017-02-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28150694

http://www.w3.org/2001/XMLSchema#string

P921

chemoradiotherapy

P932

5288719

http://www.w3.org/2001/XMLSchema#string